FDA won't comment on status of Emergency Use Authorizations for two antibody treatments

The US Food and Drug Administration told CNN Thursday morning that the agency doesn’t have any comments on the applications for Emergency Use Authorizations for Eli Lilly and Regeneron antibody treatments.
The coronavirus pandemic has brought countries to a standstill. In many places, as countries reopen, Covid-19 cases are on the rise. Follow here for the latest.

U.S. allows emergency use of COVID-19 antibody drug

F.D.A. Allows Expanded Use of Convalescent Plasma to Treat

Accelerating COVID-19 Therapeutic Interventions and Vaccines – NIH

Evusheld to prevent Covid-19: There won't be nearly enough for

FDA Open Meeting on Johnson & Johnson COVID-19 Vaccine, Part 5

Federal Register :: Authorizations of Emergency Use of Certain

FDA issues emergency use authorization for bebtelovimab - The

Biomedicines, Free Full-Text

Experts recommend Pfizer's COVID-19 vaccine to FDA for emergency

FDA Revokes Emergency Use Authorization for Monoclonal